Education and Training
The Medtronic RESOLUTE US Clinical Trial (R-US)
The objective of the study is to assess the safety and effectiveness of the Resolute Zotarolimus-Eluting Coronary Stent System for the treatment of de novo lesions in native coronary arteries with a reference vessel diameter (RVD) of 2.25 mm to 4.2 mm.
Stanford is currently not accepting patients for this trial.